George C - Search Results

1

Consolidation hemibody radiotherapy following induction combination chemotherapy in high-tumor-burden multiple myeloma.

MacKenzie MR, Wold H, George C, Gandara D, Ray G, Schiff S, Shields J, Artim R, Davidson H, Meyers F, et al. MacKenzie MR, et al. Among authors: george c. J Clin Oncol. 1992 Nov;10(11):1769-74. doi: 10.1200/JCO.1992.10.11.1769. J Clin Oncol. 1992. PMID: 1403058

2

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer.

Gandara DR, DeGregorio MW, Wold H, Wilbur BJ, Kohler M, Lawrence HJ, Deisseroth AB, George CB. Gandara DR, et al. Among authors: george cb. J Clin Oncol. 1986 Dec;4(12):1787-93. doi: 10.1200/JCO.1986.4.12.1787. J Clin Oncol. 1986. PMID: 3023557

3

Prolymphocytic leukemia. Serial responses to therapy.

Swift JF, Wold HG, Gandara DR, Redmond J 3rd, George CB. Swift JF, et al. Among authors: george cb. Cancer. 1984 Sep 15;54(6):978-80. doi: 10.1002/1097-0142(19840915)54:6<978::aid-cncr2820540605>3.0.co;2-h. Cancer. 1984. PMID: 6590113

4

Hepatic dysfunction and jaundice following high-dose cytosine arabinoside.

George CB, Mansour RP, Redmond J 3rd, Gandara DR. George CB, et al. Cancer. 1984 Dec 1;54(11):2360-2. doi: 10.1002/1097-0142(19841201)54:11<2360::aid-cncr2820541109>3.0.co;2-d. Cancer. 1984. PMID: 6594185

5

Dose-limiting myelosuppression associated with high-dose cisplatin (200 mg/m2) in hypertonic saline.

Gandara DR, Mansour R, Wold H, George C. Gandara DR, et al. Among authors: george c. Cancer Treat Rep. 1986 Jun;70(6):820-1. Cancer Treat Rep. 1986. PMID: 3731145 No abstract available.

6

Spinal computed tomography and computed tomographic metrizamide myelography in the early diagnosis of metastatic disease.

O'Rourke T, George CB, Redmond J 3rd, Davidson H, Cornett P, Fill WL, Spring DB, Sobel D, Dabe IB, Karl RD Jr, et al. O'Rourke T, et al. Among authors: george cb. J Clin Oncol. 1986 Apr;4(4):576-83. doi: 10.1200/JCO.1986.4.4.576. J Clin Oncol. 1986. PMID: 3958768

7

Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteria.

Gandara DR, George CB, Ries CA, Koretz MM, Lewis JP. Gandara DR, et al. Among authors: george cb. Cancer Chemother Pharmacol. 1987;19(2):165-8. doi: 10.1007/BF00254572. Cancer Chemother Pharmacol. 1987. PMID: 3568275

8

A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.

Gandara DR, Ries CA, Schiff SA, George CB, Lewis JP, Koretz MM, Carter SK. Gandara DR, et al. Among authors: george cb. Cancer Chemother Pharmacol. 1982;9(1):10-2. doi: 10.1007/BF00296753. Cancer Chemother Pharmacol. 1982. PMID: 7139848

9

Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trial.

Spiridonidis CH, Laufman LR, Carman L, Moore T, Blair S, Jones J, George C, Patel T, Roach R, Rupert R, Zangmeister J, Colborn D, Kuebler JP. Spiridonidis CH, et al. Among authors: george c. Ann Oncol. 2001 Jan;12(1):89-94. doi: 10.1023/a:1008306616994. Ann Oncol. 2001. PMID: 11249055 Free article. Clinical Trial.

10

Chronic lymphocytic leukemia with osteolytic bone lesions, hypercalcemia, and monoclonal protein.

Redmond J 3rd, Stites DP, Beckstead JH, George CB, Casavant CH, Gandara DR. Redmond J 3rd, et al. Among authors: george cb. Am J Clin Pathol. 1983 May;79(5):616-20. doi: 10.1093/ajcp/79.5.616. Am J Clin Pathol. 1983. PMID: 6188367 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,006 results

Search Page

Filters